ARROWHEAD PHARMACEUTICALS, INC. Income Taxes Paid
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Income Taxes Paid of $302.40 thousand for the 12-month period ending 2019-09-30, per its 10-K filed 2019-11-25.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2020-08-05
- ARROWHEAD PHARMACEUTICALS, INC. income taxes paid for the quarter ending 2019-09-30 was $300.00K.
- ARROWHEAD PHARMACEUTICALS, INC. income taxes paid for the quarter ending 2019-06-30 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. income taxes paid for the quarter ending 2018-09-30 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. income taxes paid for the quarter ending 2018-06-30 was $0.00.
- ARROWHEAD PHARMACEUTICALS, INC. income taxes paid for fiscal 2019 was $302.40K, a 12500.00% increase from fiscal 2018.
- ARROWHEAD PHARMACEUTICALS, INC. income taxes paid for fiscal 2018 was $2.40K, a 0.00% change from fiscal 2017.
- ARROWHEAD PHARMACEUTICALS, INC. income taxes paid for fiscal 2017 was $2.40K, a 0.00% change from fiscal 2016.
- ARROWHEAD PHARMACEUTICALS, INC. income taxes paid for fiscal 2016 was $2.40K, a 0.00% change from fiscal 2015.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month | Income Taxes Paid 98 month | Income Taxes Paid 101 month | Income Taxes Paid 104 month | Income Taxes Paid 107 month | Income Taxes Paid 110 month | Income Taxes Paid 113 month | Income Taxes Paid 116 month | Income Taxes Paid 119 month | Income Taxes Paid 122 month | Income Taxes Paid 125 month | Income Taxes Paid 128 month | Income Taxes Paid 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25 | $300.00K derived: sum of 2 quarters · filed 2020-08-05 | $302.40K 10-K · filed 2019-11-25 | |||||||||||||
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05 | $2.40K 10-Q · filed 2020-08-05 | ||||||||||||||
| 2019-03-31 | $2.40K 10-Q · filed 2020-05-07 | |||||||||||||||
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25 | $0.00 derived: sum of 2 quarters · filed 2019-11-25 | $2.40K 10-K · filed 2019-11-25 | |||||||||||||
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-05 | $2.40K 10-Q · filed 2019-08-05 | ||||||||||||||
| 2018-03-31 | $2.40K 10-Q · filed 2019-05-08 | |||||||||||||||
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25 | $0.00 derived: sum of 2 quarters · filed 2019-11-25 | $2.40K 10-K · filed 2019-11-25 | |||||||||||||
| 2017-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-07 | $2.40K 10-Q · filed 2018-08-07 | ||||||||||||||
| 2017-03-31 | $2.40K 10-Q · filed 2018-05-08 | |||||||||||||||
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | $0.00 derived: sum of 2 quarters · filed 2018-12-11 | $2.40K 10-K · filed 2018-12-11 | |||||||||||||
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $2.40K 10-Q · filed 2017-08-03 | ||||||||||||||
| 2016-03-31 | $2.40K 10-Q · filed 2017-05-03 | |||||||||||||||
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12 | $0.00 derived: sum of 2 quarters · filed 2017-12-12 | $2.40K 10-K · filed 2017-12-12 | |||||||||||||
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $2.40K 10-Q · filed 2016-08-09 | ||||||||||||||
| 2015-03-31 | $2.40K 10-Q · filed 2016-05-10 | |||||||||||||||
| 2014-09-30 | $5.86K 10-K · filed 2016-12-14 | |||||||||||||||
| 2014-03-31 | $742.50K 10-Q · filed 2014-05-06 | |||||||||||||||
| 2013-12-31 | $742.50K 10-Q · filed 2014-02-04 | |||||||||||||||
| 2013-09-30 | $742.50K 10-K · filed 2013-12-18 | |||||||||||||||
| 2013-06-30 | $742.50K 10-Q · filed 2013-08-07 | |||||||||||||||
| 2013-03-31 | $742.50K 10-Q · filed 2013-05-09 | |||||||||||||||
| 2012-12-31 | $742.50K 10-Q · filed 2013-02-13 | |||||||||||||||
| 2012-09-30 | $742.50K 10-K · filed 2012-12-28 | |||||||||||||||
| 2012-06-30 | $742.50K 10-Q · filed 2012-08-13 | |||||||||||||||
| 2012-03-31 | $742.50K 10-Q · filed 2012-05-08 | |||||||||||||||
| 2011-12-31 | $742.50K 10-Q · filed 2012-02-09 | |||||||||||||||
| 2011-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | $0.00 derived: sum of 2 quarters · filed 2012-12-28 | $742.50K 10-K · filed 2012-12-28 | $742.50K 10-Q · filed 2012-08-13 | ||||||||||||
| 2011-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-13 | $742.50K 10-Q · filed 2012-08-13 | $742.50K 10-Q · filed 2011-08-08 | |||||||||||||
| 2011-03-31 | $742.50K 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |